2-Methylnaphthalene-1,4-diamine
| Names | |
|---|---|
| Preferred IUPAC name
2-Methylnaphthalene-1,4-diamine | |
| Identifiers | |
3D model (JSmol)
|
|
| ChemSpider | |
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C11H12N2 | |
| Molar mass | 172.231 g·mol−1 |
| Appearance | yellowish crystals |
| Melting point | 110-113 °C |
| dihydrochloride is freely soluble | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
| |
2-Methylnaphthalene-1,4-diamine is a synthetic menadione analog with vitamin K activity.
2-Methylnaphthalene-1,4-diamine was first synthesized in 1925. In 1942 two different research groups noted the vitamin K activity of the compound. It forms a dihydrochloride salt (C11H14Cl2N2) with hydrochloric acid and one of the aforementioned research groups suggested the name vitamin K6 for the salt.
2-Methylnaphthalene-1,4-diamine and its dihydrochloride can be made from 2-methylnaphthalene or its close analogs. Dihydrochloride blackens without melting at about 300 °C.
4-Amino-3-methyl-1-naphthol or its dihydrochloride have not been used as commercial medicinal forms of vitamin K unlike phylloquinone and menadione for example.
Oral toxicity of dihydrochloride for rats is approximately the same as for 4-amino-2-methyl-1-naphthol hydrochloride.